{
    "Rank": 223,
    "Study": {
        "ProtocolSection": {
            "IdentificationModule": {
                "NCTId": "NCT05313074",
                "OrgStudyIdInfo": {
                    "OrgStudyId": "013_2021RC_IN695"
                },
                "Organization": {
                    "OrgFullName": "National Cancer Institute, Thailand",
                    "OrgClass": "OTHER_GOV"
                },
                "BriefTitle": "SARS-CoV-2 Specific Immune Response After COVID-19 Vaccination in Cancer Patients",
                "OfficialTitle": "SARS-CoV-2 Specific Immune Response After COVID-19 Vaccination in Cancer Patients"
            },
            "StatusModule": {
                "StatusVerifiedDate": "April 2022",
                "OverallStatus": "Completed",
                "ExpandedAccessInfo": {
                    "HasExpandedAccess": "No"
                },
                "StartDateStruct": {
                    "StartDate": "March 23, 2021",
                    "StartDateType": "Actual"
                },
                "PrimaryCompletionDateStruct": {
                    "PrimaryCompletionDate": "February 25, 2022",
                    "PrimaryCompletionDateType": "Actual"
                },
                "CompletionDateStruct": {
                    "CompletionDate": "February 25, 2022",
                    "CompletionDateType": "Actual"
                },
                "StudyFirstSubmitDate": "April 4, 2022",
                "StudyFirstSubmitQCDate": "April 4, 2022",
                "StudyFirstPostDateStruct": {
                    "StudyFirstPostDate": "April 6, 2022",
                    "StudyFirstPostDateType": "Actual"
                },
                "LastUpdateSubmitDate": "April 9, 2022",
                "LastUpdatePostDateStruct": {
                    "LastUpdatePostDate": "April 15, 2022",
                    "LastUpdatePostDateType": "Actual"
                }
            },
            "SponsorCollaboratorsModule": {
                "ResponsibleParty": {
                    "ResponsiblePartyType": "Principal Investigator",
                    "ResponsiblePartyInvestigatorFullName": "Thanarath Imsuwansri, MD",
                    "ResponsiblePartyInvestigatorTitle": "Head of Research Division",
                    "ResponsiblePartyInvestigatorAffiliation": "National Cancer Institute, Thailand"
                },
                "LeadSponsor": {
                    "LeadSponsorName": "National Cancer Institute, Thailand",
                    "LeadSponsorClass": "OTHER_GOV"
                },
                "CollaboratorList": {
                    "Collaborator": [
                        {
                            "CollaboratorName": "Mahidol University",
                            "CollaboratorClass": "OTHER"
                        }
                    ]
                }
            },
            "OversightModule": {
                "OversightHasDMC": "No",
                "IsFDARegulatedDrug": "No",
                "IsFDARegulatedDevice": "No"
            },
            "DescriptionModule": {
                "BriefSummary": "Our study highlights a low degree of neutralization-afforded protection mounted by CoronaVac in cancer patients when compared with healthy volunteers, especially patients who received chemotherapy. Further booster doses, beyond the conventional two-dose regimen might be needed for recipients of CoronaVac to maintain a long-term anamnestic response.",
                "DetailedDescription": "A total of 311 participants, including 107 patients with solid tumor and 204 healthy volunteers who received 2 doses of CoronaVac were recruited from National Cancer Institute of Thailand between 2020-2021. Blood samples were collected after second dose of CoronaVac for 15 days and the neutralizing antibody (NAb) titers were detected using live-virus neutralization.SARS-CoV-2 antibody positivity was detected in 77 (72%) patients and 199 (97.5%) healthy volunteers. Antibody positivity rate was lowest (67.2%) in patients who received chemotherapy, followed by patients with post-treatment (74.2%) and patients who planned to start treatment (91.7%). Our study highlights a low degree of neutralization-afforded protection mounted by CoronaVac in cancer patients when compared with healthy volunteers, especially patients who received chemotherapy. Further booster doses, heterologous or otherwise, beyond the conventional two-dose regimen might be needed for recipients of CoronaVac to maintain a long-term anamnestic response."
            },
            "ConditionsModule": {
                "ConditionList": {
                    "Condition": [
                        "COVID-19",
                        "Cancer"
                    ]
                },
                "KeywordList": {
                    "Keyword": [
                        "COVID-19",
                        "Cancer",
                        "Immune response"
                    ]
                }
            },
            "DesignModule": {
                "StudyType": "Interventional",
                "PhaseList": {
                    "Phase": [
                        "Not Applicable"
                    ]
                },
                "DesignInfo": {
                    "DesignAllocation": "Non-Randomized",
                    "DesignInterventionModel": "Parallel Assignment",
                    "DesignInterventionModelDescription": "Cancer patients and healthy volunteers will be compared for effectiveness of CoronaVac vaccine in parallel after 2 doses of vaccination for 15 days by neutralizing antibody test",
                    "DesignPrimaryPurpose": "Prevention",
                    "DesignMaskingInfo": {
                        "DesignMasking": "None (Open Label)",
                        "DesignMaskingDescription": "All participants, including patients with solid tumor and healthy volunteers will be received 2 doses of CoronaVac at National Cancer Institute of Thailand between 2020-2021. Blood samples will be collected after second dose of Sinovac for 15 days and the neutralizing antibody (NAb) titers will be detected using live-virus neutralization"
                    }
                },
                "EnrollmentInfo": {
                    "EnrollmentCount": "311",
                    "EnrollmentType": "Actual"
                }
            },
            "ArmsInterventionsModule": {
                "ArmGroupList": {
                    "ArmGroup": [
                        {
                            "ArmGroupLabel": "Healthy volunteers",
                            "ArmGroupType": "Placebo Comparator",
                            "ArmGroupDescription": "Healthcare workers at National Cancer Institute",
                            "ArmGroupInterventionList": {
                                "ArmGroupInterventionName": [
                                    "Biological: CoronaVac vaccine"
                                ]
                            }
                        },
                        {
                            "ArmGroupLabel": "Cancer patients",
                            "ArmGroupType": "Active Comparator",
                            "ArmGroupDescription": "Cancer patients were divided into 3 groups based on treatment status including\n\nactive cancer on treatment\nPlanned to start treatment\nPost-treatment (<6 months)",
                            "ArmGroupInterventionList": {
                                "ArmGroupInterventionName": [
                                    "Biological: CoronaVac vaccine"
                                ]
                            }
                        }
                    ]
                },
                "InterventionList": {
                    "Intervention": [
                        {
                            "InterventionType": "Biological",
                            "InterventionName": "CoronaVac vaccine",
                            "InterventionDescription": "An inactivated virus COVID-19 vaccine developed by the Chinese company Sinovac Biotech.",
                            "InterventionArmGroupLabelList": {
                                "InterventionArmGroupLabel": [
                                    "Cancer patients",
                                    "Healthy volunteers"
                                ]
                            },
                            "InterventionOtherNameList": {
                                "InterventionOtherName": [
                                    "Sinovac"
                                ]
                            }
                        }
                    ]
                }
            },
            "OutcomesModule": {
                "PrimaryOutcomeList": {
                    "PrimaryOutcome": [
                        {
                            "PrimaryOutcomeMeasure": "Immune response of Coronavac vaccine in Thai cancer patients",
                            "PrimaryOutcomeDescription": "Immune response of of the inactivated COVID-19 vaccine (Coronavac) in Thai cancer patients",
                            "PrimaryOutcomeTimeFrame": "15 days after 2 doses of vaccination"
                        }
                    ]
                }
            },
            "EligibilityModule": {
                "EligibilityCriteria": "Inclusion Criteria:\n\nMale or Female age at least 18 years\nPatients with a diagnosis of solid tumors\nAbility to understand the patient information and study consent. Signed and dated written informed consent must be available before performing any study-related procedure\nWilling and able to comply with the study procedures.\nWilling to receive a Coronavac vaccine (Sinovac).\n\nExclusion Criteria:\n\nPatients who cannot provide consent",
                "HealthyVolunteers": "Accepts Healthy Volunteers",
                "Gender": "All",
                "MinimumAge": "18 Years",
                "StdAgeList": {
                    "StdAge": [
                        "Adult",
                        "Older Adult"
                    ]
                }
            },
            "ContactsLocationsModule": {
                "OverallOfficialList": {
                    "OverallOfficial": [
                        {
                            "OverallOfficialName": "Thanarath Imsuwansri, MD",
                            "OverallOfficialAffiliation": "National Cancer Institute of Thailand",
                            "OverallOfficialRole": "Principal Investigator"
                        }
                    ]
                },
                "LocationList": {
                    "Location": [
                        {
                            "LocationFacility": "National Cancer Institute",
                            "LocationCity": "Ratchathewi",
                            "LocationState": "Bangkok",
                            "LocationZip": "10400",
                            "LocationCountry": "Thailand"
                        }
                    ]
                }
            }
        },
        "DerivedSection": {
            "MiscInfoModule": {
                "VersionHolder": "September 08, 2023"
            },
            "ConditionBrowseModule": {
                "ConditionMeshList": {
                    "ConditionMesh": [
                        {
                            "ConditionMeshId": "D000086382",
                            "ConditionMeshTerm": "COVID-19"
                        }
                    ]
                },
                "ConditionAncestorList": {
                    "ConditionAncestor": [
                        {
                            "ConditionAncestorId": "D000011024",
                            "ConditionAncestorTerm": "Pneumonia, Viral"
                        },
                        {
                            "ConditionAncestorId": "D000011014",
                            "ConditionAncestorTerm": "Pneumonia"
                        },
                        {
                            "ConditionAncestorId": "D000012141",
                            "ConditionAncestorTerm": "Respiratory Tract Infections"
                        },
                        {
                            "ConditionAncestorId": "D000007239",
                            "ConditionAncestorTerm": "Infections"
                        },
                        {
                            "ConditionAncestorId": "D000014777",
                            "ConditionAncestorTerm": "Virus Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000018352",
                            "ConditionAncestorTerm": "Coronavirus Infections"
                        },
                        {
                            "ConditionAncestorId": "D000003333",
                            "ConditionAncestorTerm": "Coronaviridae Infections"
                        },
                        {
                            "ConditionAncestorId": "D000030341",
                            "ConditionAncestorTerm": "Nidovirales Infections"
                        },
                        {
                            "ConditionAncestorId": "D000012327",
                            "ConditionAncestorTerm": "RNA Virus Infections"
                        },
                        {
                            "ConditionAncestorId": "D000008171",
                            "ConditionAncestorTerm": "Lung Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000012140",
                            "ConditionAncestorTerm": "Respiratory Tract Diseases"
                        }
                    ]
                },
                "ConditionBrowseLeafList": {
                    "ConditionBrowseLeaf": [
                        {
                            "ConditionBrowseLeafId": "M2562",
                            "ConditionBrowseLeafName": "COVID-19",
                            "ConditionBrowseLeafAsFound": "COVID-19",
                            "ConditionBrowseLeafRelevance": "high"
                        },
                        {
                            "ConditionBrowseLeafId": "M13594",
                            "ConditionBrowseLeafName": "Pneumonia",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M13604",
                            "ConditionBrowseLeafName": "Pneumonia, Viral",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M9973",
                            "ConditionBrowseLeafName": "Infections",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M6058",
                            "ConditionBrowseLeafName": "Communicable Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M14668",
                            "ConditionBrowseLeafName": "Respiratory Tract Infections",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M17212",
                            "ConditionBrowseLeafName": "Virus Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M20180",
                            "ConditionBrowseLeafName": "Coronavirus Infections",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M6245",
                            "ConditionBrowseLeafName": "Coronaviridae Infections",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M23375",
                            "ConditionBrowseLeafName": "Nidovirales Infections",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M14839",
                            "ConditionBrowseLeafName": "RNA Virus Infections",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M10858",
                            "ConditionBrowseLeafName": "Lung Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M14667",
                            "ConditionBrowseLeafName": "Respiratory Tract Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        }
                    ]
                },
                "ConditionBrowseBranchList": {
                    "ConditionBrowseBranch": [
                        {
                            "ConditionBrowseBranchAbbrev": "BC01",
                            "ConditionBrowseBranchName": "Infections"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "BC08",
                            "ConditionBrowseBranchName": "Respiratory Tract (Lung and Bronchial) Diseases"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "All",
                            "ConditionBrowseBranchName": "All Conditions"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "BC23",
                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                        }
                    ]
                }
            },
            "InterventionBrowseModule": {
                "InterventionBrowseLeafList": {
                    "InterventionBrowseLeaf": [
                        {
                            "InterventionBrowseLeafId": "M17050",
                            "InterventionBrowseLeafName": "Vaccines",
                            "InterventionBrowseLeafRelevance": "low"
                        }
                    ]
                },
                "InterventionBrowseBranchList": {
                    "InterventionBrowseBranch": [
                        {
                            "InterventionBrowseBranchAbbrev": "All",
                            "InterventionBrowseBranchName": "All Drugs and Chemicals"
                        }
                    ]
                }
            }
        }
    }
}